Benjamin Edwards Inc’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.41M Buy
34,851
+9,058
+35% +$625K 0.03% 422
2025
Q1
$1.79M Sell
25,793
-1,132
-4% -$78.6K 0.03% 445
2024
Q4
$2.32M Buy
26,925
+1,228
+5% +$106K 0.03% 411
2024
Q3
$3.06M Buy
25,697
+22,242
+644% +$2.65M 0.04% 347
2024
Q2
$493K Buy
3,455
+87
+3% +$12.4K 0.09% 222
2024
Q1
$432K Sell
3,368
-25
-0.7% -$3.21K 0.09% 236
2023
Q4
$351K Buy
3,393
+27
+0.8% +$2.79K 0.08% 234
2023
Q3
$306K Sell
3,366
-30
-0.9% -$2.73K 0.07% 222
2023
Q2
$275K Buy
3,396
+3,310
+3,849% +$268K 0.06% 236
2023
Q1
$7K Hold
86
﹤0.01% 608
2022
Q4
$6K Hold
86
﹤0.01% 628
2022
Q3
$4K Hold
86
﹤0.01% 626
2022
Q2
$5K Hold
86
﹤0.01% 622
2022
Q1
$5K Sell
86
-746
-90% -$43.4K ﹤0.01% 652
2021
Q4
$47K Buy
+832
New +$47K 0.02% 422